taurolidine has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouchier-Hayes, DJ; Da Costa, ML; Redmond, HP | 1 |
1 other study(ies) available for taurolidine and B16 Melanoma
Article | Year |
---|---|
Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Topics: Animals; Antineoplastic Agents; Cell Division; Cytotoxicity, Immunologic; Female; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Laparoscopy; Laparotomy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplastic Cells, Circulating; Taurine; Thiadiazines; Tumor Cells, Cultured | 2001 |